Are Two Heads Better Than One? Not At FDA
The RPM Report, By Ramsey Baghdadi,Monday, March 23 2009
Commissioner nominee Hamburg’s first challenge will be establishing that she is singular leader despite the simultaneous nomination of principle deputy Sharfstein. Administration says there is no truth to premise Hamburg will focus on food while Sharfstein oversees drug issues—but don’t be surprised if it works out that way.
Sorry, the comment form is closed at this time.
-
Archives
- March 2009 (176)
- February 2009 (115)
-
Categories
- 18162508
- Anti-Depressant
- Bio Tech Industry
- Caregiver
- Clinical Trials
- Coffee
- Depression
- Documentary
- Electronic Medcial Records
- EMEA
- Environmental Causes
- Ethics
- European Medicines Agency
- FDA
- Generic Drugs
- Genetic Mutation
- Genetics
- Health and Human Services Dept
- Healthcare Reform
- HHS
- IRB
- Law
- Legislation
- Lobbying
- Medical Devices
- Medicare
- Mental Health
- MJ Fox
- Neurotoxins
- NHS (United Kingdom)
- NIH
- NIH Funding
- Obama Administration
- Orphan Drugs
- Other Research
- Parkinson's related video
- PD Cause
- PD Clinical Trials
- PD Medical Clinics
- PD Personal Stories
- PD Prevention Research
- PD Research
- PD Support Group News
- PD Surgery
- PD Therapies
- Pharmaceutical Industry
- Prescription Drugs
- PWP In The News
- Religion
- Research with potential for PD
- Social Security
- Social Web Sites
- Stimulus Package
- Stress Effect
- Uncategorized
- YouTube
-
RSS
Entries RSS
Comments RSS